USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: ONCOTIDE PHARMACEUTICALS, INC.
Address: BOX 110606, 79 TW ALEXANDER DR, BLDG 4401
RESEARCH TRIANGLE PARK, NC 27709-0606
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $600,000.00 2

Award List:

Novel SET Antagonists for the Treatment of Chronic Myelogenous Leukemia

Award Year / Program / Phase: 2012 / STTR / Phase I
Agency: HHS
Research Institution: OREGON HEALTH AND SCIENCE UNIVERSITY
Principal Investigator: Dale J. Christensen – 919-801-2911
Award Amount: $300,000.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Chronic Myelogenous Leukemia (CML) affects nearly 14,000 patients worldwide and is a disorder of the pluripotent hematopoietic stem cells with two distinct phases. The protracted myelopoliferative chronic phase is followed by a rapidly fatal blast crisis. In… More

Targeting c-Myc and Akt with PP2A reactivation therapy for the treatment of breas

Award Year / Program / Phase: 2013 / STTR / Phase I
Agency: HHS
Research Institution: OREGON HEATLH AND SCIENCE UNIVERSITY
Principal Investigator: Dale J. Christensen – 919-801-2911
Award Amount: $300,000.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Each year in the United States over 270,000 women will be diagnosed with breast cancer and over 40,000 will die from the disease. While multiple forms of breast cancer exist, a common theme in most of the forms involvesaberrations in signal transduction pathways… More